Johnson & Johnson Diabetes Institute To Provide Education, Training to Health Professionals
- Details
- Category: Business
With mounting evidence that many health professionals lack the training and skills to combat the nation's growing epidemic of diabetes, the Johnson & Johnson Diabetes Institute, LLC opened its first training center in the U.S. to improve how practitioners deliver diabetes care in local communities.
Forest Laboratories, Inc. Announces Amendment to Bystolic(TM) (nebivolol) Agreement
- Details
- Category: Product
Forest Laboratories Holdings, Ltd., a wholly owned subsidiary of Forest Laboratories, Inc. (NYSE: FRX), announced that it and Mylan Inc. (NYSE: MYL) have amended their January 2006 agreement to commercialize, develop and distribute the novel beta blocker Bystolic(TM) (nebivolol), which is currently approved in the United States for the treatment of hypertension.
The Bayer Group once again considerably improved its sales and earnings in 2007
- Details
- Category: Bayer
The Bayer Group once again considerably improved its sales and earnings in 2007, and also exceeded its performance targets. "2007 was Bayer's most successful year to date," said Management Board Chairman Werner Wenning on Thursday at the Spring Financial News Conference in Leverkusen.
Celebrity Chef Offers Recipes and Shortcuts in the Kitchen to People with Rheumatoid Arthritis
- Details
- Category: Bristol-Myers Squibb
Life and Style Expert Sandra Lee's Semi-Homemade approach to cooking, which involves using 70 percent store-bought items and 30 percent homemade items in every meal, makes life easier for millions of busy Americans. Unknown to most, Lee's signature style was strongly influenced by her grandmother, who suffered from rheumatoid arthritis (RA), a chronic, progressive disease of the immune system that causes joint damage as well as chronic pain, stiffness, swelling and fatigue.
AstraZeneca Provides Update On RECENTIN⢠Clinical Development Programme
- Details
- Category: AstraZeneca
AstraZeneca today announced that its HORIZON III Phase II/III head-to-head study of RECENTIN™ (cediranib, AZD2171) with chemotherapy versus bevacizumab (Avastin™) with chemotherapy in patients with first line metastatic colorectal cancer (CRC) will be progressing directly into Phase III at 20mg.
Pfizer Voluntarily Withdraws Lipitor Advertising Featuring Dr. Robert Jarvik
- Details
- Category: Pfizer
Pfizer said today that it is voluntarily withdrawing Lipitor advertising and promotion featuring Dr. Robert Jarvik and committing to ensuring greater clarity in the roles and responsibilities of its spokespeople in its consumer advertising and promotion.
Novartis Vaccines Institute for Global Health (NVGH) is the first institute with nonprofit mission
- Details
- Category: Novartis
Novartis announced the opening of a new research institute in Siena with a nonprofit mission to exclusively focus on the development of vaccines for diseases of the developing world. The Novartis Vaccines Institute for Global Health (NVGH) is the first institute of its kind to be set up by a major vaccine manufacturer.
More Pharma News ...
- Nycomed creates a leading specialty pharmaceutical player in dermatology
- AstraZeneca To Appeal Judgment In Alabama Medical Pricing Case
- Shire plc accelerating new product sales drive revenue growth of 36%
- New price reductions for GSK antiretrovirals in the world's poorest countries
- Onyx Pharmaceuticals Reports Fourth Quarter and Twelve-Month 2007 Financial Results
- Bayer and Onyx Provide Update on Phase III Trial of Nexavar®
- Trasylol® - One Thousand Lives A Month